Small Molecules in FDA’s New Drug Approvals 2025: Implications for 2026 Drug Development
Small molecules still dominate FDA approvals, but rising stereochemical and solid-state complexity demands stronger CMC strategies for 2026 readiness.
Cutting edge process development insights and news from APC.
Small molecules still dominate FDA approvals, but rising stereochemical and solid-state complexity demands stronger CMC strategies for 2026 readiness.
For the synthesis & crystallization of APIs, Mixed Suspension Mixed Product Removal Crystallizers (MSMPRCs) can help address common issues in batch production.
Indium chloride catalysed benzyl bromination using continuous flow technology. Thankappan, H., Burke, C., & Glennon, B. (2023)
[Webinar] Learn more about the use of Continuous Processing for Crystallization.
Discover the industry drivers for Continuous Processing and how it accelerates development and benefits your manufacturing strategy.
Our expert, Dr. Jacek Zeglinski talks about the various challenges which drug substance developers face when seeking to develop material suitable for tabletting
[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.